Sökning: id:"swepub:oai:DiVA.org:oru-4127" > Discovery of phenyl...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 02913naa a2200625 4500 | |
001 | oai:DiVA.org:oru-4127 | |
003 | SwePub | |
008 | 071106s2006 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-41272 URI |
024 | 7 | a https://doi.org/10.1021/jm06095662 DOI |
040 | a (SwePub)oru | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Hu, Baihua4 aut |
245 | 1 0 | a Discovery of phenyl acetic acid substituted quinolines as novel liver X receptor agonists for the treatment of atherosclerosis |
264 | c 2006-09-09 | |
264 | 1 | b American Chemical Society (ACS),c 2006 |
338 | a print2 rdacarrier | |
500 | a Letter. | |
520 | a A structure-based approach was used to optimize our new class of quinoline LXR modulators leading to phenyl acetic acid substituted quinolines 15 and 16. Both compounds displayed good binding affinity for LXRâ and LXRR and were potent activators in LBD transactivation assays. The compounds also increased expression of ABCA1 and stimulated cholesterol efflux in THP-1 cells. Quinoline 16 showed good oral bioavailability and in vivo efficacy in a LDLr knockout mouse model for lesions. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Farmaceutiska vetenskaper0 (SwePub)301012 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Pharmaceutical Sciences0 (SwePub)301012 hsv//eng |
653 | a Pharmaceutical biochemistry | |
653 | a Farmaceutisk biokemi | |
653 | a Biochemistry | |
653 | a Biokemi | |
700 | 1 | a Collini, Michael4 aut |
700 | 1 | a Unwalla, Rayomand4 aut |
700 | 1 | a Miller, Christopher4 aut |
700 | 1 | a Singhaus, Robert4 aut |
700 | 1 | a Quinet, Elaine4 aut |
700 | 1 | a Savio, Dawn4 aut |
700 | 1 | a Halpern, Anita4 aut |
700 | 1 | a Basso, Michael4 aut |
700 | 1 | a Keith, James4 aut |
700 | 1 | a Clerin, Valerie4 aut |
700 | 1 | a Chen, Liang4 aut |
700 | 1 | a Resmini, Christine4 aut |
700 | 1 | a Liu, Qiang-Yuan4 aut |
700 | 1 | a Feingold, Irene4 aut |
700 | 1 | a Huselton, Christine4 aut |
700 | 1 | a Azam, Farooq4 aut |
700 | 1 | a Farnegardh, Mathias4 aut |
700 | 1 | a Enroth, Cristoferu Örebro universitet,Institutionen för naturvetenskap,Molekylär biokemi4 aut0 (Swepub:oru)creh |
700 | 1 | a Bonn, Tomas4 aut |
700 | 1 | a Goos-Nilsson, Annika4 aut |
700 | 1 | a Wilhelmsson, Anna4 aut |
700 | 1 | a Nambi, Ponnal4 aut |
700 | 1 | a Wrobel, Jay4 aut |
710 | 2 | a Örebro universitetb Institutionen för naturvetenskap4 org |
773 | 0 | t Journal of Medicinal Chemistryd : American Chemical Society (ACS)g 49:21, s. 6151-6154q 49:21<6151-6154x 0022-2623x 1520-4804 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-4127 |
856 | 4 8 | u https://doi.org/10.1021/jm0609566 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.